Know Labs News

Know Labs Price Target Announced at $1.00/Share by Benchmark

Know Labs Price Target Announced at $1.00/Share by Benchmark

Dow JonesApr 8 20:14

Know Labs Initiated at Speculative Buy by Benchmark

Know Labs Initiated at Speculative Buy by Benchmark

Dow JonesApr 8 20:14

Know Labs (KNW.US) was first covered by Benchmark, which gave it a Speculative Buy rating, with a target price of $1.00.

Know Labs (KNW.US) was first covered by Benchmark, which gave it a Speculative Buy rating, with a target price of $1.00.

Zhitong FinanceApr 8 20:10

Benchmark Initiates Coverage On Know Labs With Speculative Buy Rating, Announces Price Target of $1

Benchmark analyst Bruce Jackson initiates coverage on Know Labs with a Speculative Buy rating and announces Price Target of $1.

Analyst UpgradesApr 8 20:03

Know Labs Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/08/2024 56.01% Benchmark → $1 Initiates Coverage On → Speculative Buy

BenzingaApr 8 20:02

Know Labs to Present Clinical Research at the 2024 American Physiology Summit

The Company demonstrates significant progress since presenting at last year's Summit. Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been

BusinesswireApr 5 21:00

Know Labs Reports Promising Results From Clinical Study

TipRanksMar 7 05:25

Know Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study

Know Labs' first study including participants with diabetes and venous blood as a comparative reference demonstrates its proprietary sensor's accuracy and medical application.SEATTLE--(BUSINESS WIRE)-

BusinesswireMar 6 22:00

Dawson James Downgrades Know Labs Stock to Neutral, Withdraws 12-month PT

InvestingMar 5 22:42

Know Labs to Raise up to $12M for Non-invasive CGM Tech

MassDeviceMar 2 04:46

Know Labs Secures $12 Million Investment From Lind

InvestingMar 1 06:10

Know Labs Secures U.S. $12 Million Funding for Company's Further Execution on Its Clinical Research and Development Initiatives

Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has entered into a funding agreement for an investment of up to $12 million, of which it has executed a

BusinesswireMar 1 05:15

Know Labs Announces the KnowU, Its Wearable Non-Invasive Continuous Glucose Monitor

The KnowU incorporates the sensor intended for FDA submission Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the KnowU, its wearable

BusinesswireFeb 27 22:00

Earnings Call Summary | Know Labs(KNW.US) Q1 2024 Earnings Conference

The following is a summary of the Know Labs, Inc. (KNW) Q1 2024 Earnings Call Transcript:Financial Performance:Know Labs reported a Q1 net loss of $3.45 million, down 9.8% from a net loss of $3.82 mil

Futu NewsFeb 15 09:08 · Conference Call

Know Labs Q1 EPS $(0.04) Up From $(0.08) YoY

Know Labs (AMEX:KNW) reported quarterly losses of $(0.04) per share. This is a 50 percent increase over losses of $(0.08) per share from the same period last year.

BenzingaFeb 15 06:04

Know Labs GAAP EPS of -$0.04

Seeking AlphaFeb 15 05:25

Press Release: Know Labs, Inc. Reports First Quarter FY2024 Results

Know Labs, Inc. Reports First Quarter FY2024 Results SEATTLE--(BUSINESS WIRE)--February 14, 2024-- Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic tech

Dow JonesFeb 15 05:15

Earnings Scheduled For February 14, 2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion. • CAE (NYSE:CAE) is estimated to report quarterl

BenzingaFeb 14 17:48

Press Release: Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024

Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024 SEATTLE--(BUSINESS WIRE)--February 07, 2024-- Know Labs, Inc. (NYSE American: KNW), an emerging develope

Dow JonesFeb 7 22:07

Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

The Company to present updated clinical research results and developments of its non-invasive blood glucose monitor Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology,

BusinesswireJan 23 22:00